Ben Atwell

United KingdomUnited Kingdom

PublicScheme

target

Shire

bidder

Takeda Pharmaceutical Company

£44,351m

154 dealmakers

PublicAcquisitionSchemeMajority

target

Sinclair Pharma

bidder

Huadong Medicine Co

£179m

27 dealmakers

AcquisitionPublicSchemeMajorityPrivate Equity

target

Btg

bidder

Boston Scientific Corporation

£3,029m

64 dealmakers

PrivateAcquisitionMajority

Medical Equipment

target

Ceterix Orthopaedics

bidder

Smith & Nephew

£82m

7 dealmakers

PublicAcquisition

target

Osiris Therapeutics

bidder

Smith & Nephew

£505m

37 dealmakers

AcquisitionPrivateMajority

Medical Equipment

target

Leaf Healthcare

bidder

Smith & Nephew

value n/a

6 dealmakers

Switzerland

Private EquityAcquisitionPrivateMajorityCross Border

target

Nestle Skin Health

bidder

Eqt Partners

£7,808m

196 dealmakers

Germany

PrivateAcquisitionMajorityDomestic

target

Brainlab (orthopaedic Joint Reconstruction Business)

bidder

Smith & Nephew

value n/a

4 dealmakers

Medical Services

PrivateAcquisition

target

Blue Earth Diagnostics

bidder

Bracco Imaging

£390m

31 dealmakers

Germany

PrivateAcquisitionMajority

target

Expedeon (proteomics And Immunology Business)

bidder

Abcam

£103m

16 dealmakers

AcquisitionPublicMajorityPrivatisationCross Border

target

Consort Medical

bidder

Recipharm

£627m

36 dealmakers

Private EquityAcquisitionPrivate

target

Achilles Therapeutics

bidder

Syncona

£100m

8 dealmakers

AcquisitionMinorityPublic

target

Karuna Therapeutics

bidder

Goldman Sachs

£152m

7 dealmakers

MinorityAcquisitionPrivatePrivate Equity

target

Azeria Therapeutics

bidder

Sixth Element Capital

£32m

7 dealmakers

AcquisitionPrivateMajority

target

Marker Gene Technologies

bidder

Abcam

value n/a

6 dealmakers

AcquisitionPublicMinorityPrivate Equity

target

Hutchison China Meditech

bidder

General Atlantic

£80m

10 dealmakers

Customer Relationship Management

MajorityPublicAcquisitionPrivate EquityDomestic

target

Cello Health

bidder

Arsenal Capital Partners

£181m

31 dealmakers

PublicMinorityAcquisitionPrivate EquityCross Border

target

Hutchison China Meditech

bidder

Canada Pension Plan Investment Board

£75m

13 dealmakers

Switzerland

Cross BorderPrivateAcquisitionMajority

target

Om Pharma

bidder

Optimus Holding

£369m

32 dealmakers

PrivateAcquisitionCross BorderPrivate EquityMajority

target

Hutchison China Meditech

bidder

Canada Pension Plan Investment Board

£75m

19 dealmakers

PublicVenture CapitalPrivate EquityAcquisitionDomesticMinority

target

Abcam

bidder

Durable Capital Partners

£110m

4 dealmakers

MergerPublicMajorityAcquisitionCross Border

target

Gw Pharmaceuticals

bidder

Jazz Pharmaceuticals

£5,266m

85 dealmakers

PrivateMajorityCross BorderAcquisition

Medical Services

target

Radmd

bidder

Medica Group

£15m

16 dealmakers

PrivatePrivate EquityAcquisitionDomesticMinority

target

Hutchison China Meditech

bidder

Bpea Eqt

£72m

16 dealmakers

Cross BorderAcquisitionPublicMajorityPrivate EquityTender Offer

target

Vectura Group

bidder

Philip Morris International

£1,025m

97 dealmakers

PrivateAcquisitionMajorityCross Border

target

BIOVISION

bidder

Abcam

£244m

20 dealmakers

China

Private EquityPrivateMajorityDomesticAcquisition

target

Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company

bidder

Gl Capital Group

£127m

13 dealmakers

Cross BorderAcquisitionMajorityPrivate

Health Care Facilities

target

Gyroscope Therapeutics

bidder

Novartis

£1,132m

20 dealmakers

Private EquityCross BorderVenture CapitalAcquisitionMinorityPrivate

Medical Equipment

target

Omass Therapeutics

bidder

Oxford University Clinic

£75m

13 dealmakers

PrivatePrivate EquityMinorityDomesticVenture CapitalAcquisition

target

Swanbio Therapeutics

bidder

Syncona

£45m

10 dealmakers

MajorityAcquisitionCross BorderPublic

Health Care Facilities

target

Mediclinic International

bidder

Remgro

£3,700m

152 dealmakers

AcquisitionMajorityPublicDomestic

target

F-STAR

bidder

Invox Pharma

£131m

20 dealmakers

Cross BorderMajorityTender OfferAcquisitionPublic

target

Applied Genetic Technologies Corporation

bidder

Syncona

£64m

9 dealmakers

PrivateDomesticMajorityAcquisition

target

Eleusis Therapeutics

bidder

Beckley Psytech

value n/a

8 dealmakers

Netherlands

Private EquityCross BorderAcquisitionMajorityPrivate

target

Neogene Therapeutics

bidder

Astrazeneca

£264m

60 dealmakers

Telecommunications Services: Other

MajorityPublicPrivate EquityDomesticAcquisition

target

Medica Group

bidder

Ik Partners

£269m

30 dealmakers

MinorityPrivateAcquisitionDomestic

target

Quell Therapeutics

bidder

Astrazeneca

value n/a

6 dealmakers

AcquisitionCross BorderMinorityPrivatePrivate Equity

target

Beacon Therapeutics

bidder

Syncona

£96m

8 dealmakers

AcquisitionPublicDomesticMajorityScheme

target

Freeline Therapeutics

bidder

Syncona

£11m

6 dealmakers

MergerPublicAcquisitionDomesticMajority

target

Karuna Therapeutics

bidder

Bristol Myers Squibb Company

£10,033m

55 dealmakers

Private EquityMinorityCross BorderPrivateAcquisitionVenture Capital

target

Apollo Therapeutics

bidder

Patient Square Capital

£179m

13 dealmakers

AcquisitionMajorityPrivateDomestic

Digital Services

target

Virtual Therapeutics

bidder

Akili Interactive Labs

value n/a

9 dealmakers

DomesticMinorityPrivatePrivate EquityVenture CapitalAcquisition

target

Beacon Therapeutics

bidder

Syncona

£134m

10 dealmakers

Private EquityAcquisitionPrivateDomesticMajority

target

Yellowstone Biosciences

bidder

Syncona

£16m

7 dealmakers